H.R. 6485 · House bill · 119th Congress
Skinny Labels, Big Savings Act Introduced Dec 5, 2025 In committee Dec 5, 2025 Judiciary Passed the House (not yet) Passed the Senate (not yet) Law (not yet) What it would change (1) About this text
1 section of the Code · 3 changes asked for
Text: introduced in House Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Dec 5, 2025 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
This change would add new safe harbors to the patent infringement section for "skinny label" drugs, meaning generic or biosimilar products approved for only some of the uses of the brand product. For generic and similar drug applications that carve out a patented method of use, applying for approval, marketing with the approved label, and calling the product a generic or therapeutic equivalent would not be infringement of that method claim. A parallel rule would cover biosimilar applications. Both rules would not apply if the labeling, promotion or marketing references the patented use. The change also adds definitions and moves two existing subsections to (k) and (l).
This is the note on the one section the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
35 U.S.C. Chapter 28 · Infringement of Patents 1 section § 271 Infringement of patent Shown